Published in Hepatitis Weekly, January 15th, 2007
Study 1: A report, "Clinical significance of hepatitis B e antigen level measurement during long-term lamivudine therapy in chronic hepatitis B patients with e antigen positive," is newly published data in World Journal of Gastroenterology. In this recently published article, scientists in South Korea conducted a study "To determine the changes of quantitative hepatitis B e antigen (HBeAg) that predicts early detection of non-response or breakthrough to long-term lamivudine (LAM) therapy. Among HBeAg positive chronic hepatitis B patients who failed to achieve HBeAg...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly